FOXO3a Protects against Kidney Injury in Type II Diabetic Nephropathy by Promoting Sirt6 Expression and Inhibiting Smad3 Acetylation
Diabetic nephropathy (DN) is the most common cause of end-stage renal disease. Although numerous reports have demonstrated a correlation between epithelial-mesenchymal transition (EMT) and renal fibrosis, how these processes lead to tubular dysfunction remains unclear. Here, we show that FOXO3a prot...
Main Authors: | Xiaowei Wang, Tingting Ji, Xiaoying Li, Xiaolei Qu, Shoujun Bai |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2021/5565761 |
Similar Items
-
The role of SIRT6 and FOXO3a acetylation in the development of drug resistance in breast cancer
by: Khongkow, Mattaka
Published: (2014) -
Aucubin alleviates diabetic nephropathy by inhibiting NF-κB activation and inducing SIRT1/SIRT3-FOXO3a signaling pathway in high-fat diet/streptozotocin-induced diabetic mice
by: Bo Ma, et al.
Published: (2020-01-01) -
N1-Methylnicotinamide Improves Hepatic Insulin Sensitivity via Activation of SIRT1 and Inhibition of FOXO1 Acetylation
by: Jingfan Zhang, et al.
Published: (2020-01-01) -
hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy
by: Shoujun Bai, et al.
Published: (2021-01-01) -
EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer
by: Zimam Mahmud, et al.
Published: (2019-07-01)